Parallel Advisors, LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,634
-22.0%
1930.0%0.00%0.0%
Q2 2023$41,852
+21.9%
193
+2.1%
0.00%0.0%
Q1 2023$34,330
-9.0%
189
-1.6%
0.00%
-50.0%
Q4 2022$37,728
+654.6%
192
+772.7%
0.00%
Q3 2022$5,000
+150.0%
22
+15.8%
0.00%
Q2 2022$2,00019
+1800.0%
0.00%
Q4 2021$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q3 2020$384,000
-30.6%
4,9650.0%0.02%
-33.3%
Q2 2020$553,0004,9650.04%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders